{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:12:34Z","timestamp":1784128354537,"version":"3.55.0"},"reference-count":77,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100003132","name":"Agentschap voor Innovatie door Wetenschap en Technologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004497","name":"Onderzoeksraad, KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2017.00339","type":"journal-article","created":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T04:26:31Z","timestamp":1512361591000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["The Stem Cell Connection of Pituitary Tumors"],"prefix":"10.3389","volume":"8","author":[{"given":"Hugo","family":"Vankelecom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heleen","family":"Roose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,12,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nrendo.2011.40","article-title":"Pathogenesis of pituitary tumors","volume":"7","author":"Melmed","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","article-title":"Overview of the 2017 WHO classification of pituitary tumors","volume":"28","author":"Mete","year":"2017","journal-title":"Endocr Pathol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"11482","DOI":"10.1073\/pnas.1101553108","article-title":"Increased Wingless (Wnt) signaling in pituitary progenitor\/stem cells gives rise to pituitary tumors in mice and humans","volume":"108","author":"Gaston-Massuet","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00401-012-0957-9","article-title":"Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma","volume":"124","author":"Andoniadou","year":"2012","journal-title":"Acta Neuropathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1210\/jc.2011-2187","article-title":"Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET\/GFRA3 receptors","volume":"97","author":"Garcia-Lavandeira","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1172\/JCI200320401.Introduction","article-title":"Mechanisms for pituitary tumorigenesis : the plastic pituitary","volume":"112","author":"Melmed","year":"2003","journal-title":"J Clin Invest"},{"key":"B7","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1365-2265.2008.03288.x","article-title":"Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas","volume":"69","author":"Van Der Klaauw","year":"2008","journal-title":"Clin Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11102-008-0088-4","article-title":"Hypopituitarism following radiotherapy","volume":"12","author":"Darzy","year":"2009","journal-title":"Pituitary"},{"key":"B9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nrclinonc.2009.127","article-title":"Role of cancer stem cells in pancreatic ductal adenocarcinoma","volume":"6","author":"Sergeant","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1586\/edm.09.17","article-title":"Cancer stem cells in cutaneous melanoma","volume":"4","author":"Wouters","year":"2009","journal-title":"Expert Rev Dermatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nm.2304","article-title":"The cancer stem cell: premises, promises and challenges","volume":"17","author":"Clevers","year":"2011","journal-title":"Nat Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.med.58.062105.204854","article-title":"Cancer stem cells: models and concepts","volume":"58","author":"Dalerba","year":"2007","journal-title":"Annu Rev Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nature07602","article-title":"Crypt stem cells as the cells-of-origin of intestinal cancer","volume":"457","author":"Barker","year":"2009","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e33544","DOI":"10.1371\/journal.pone.0033544","article-title":"A model of cancer stem cells derived from mouse induced pluripotent stem cells","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nature13305","article-title":"SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma","volume":"511","author":"Boumahdi","year":"2014","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"7431","DOI":"10.1073\/pnas.1012720108","article-title":"Identifying the cellular origin of squamous skin tumors","volume":"108","author":"Lapouge","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B17","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1126\/science.1224676","article-title":"Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas","volume":"337","author":"Schepers","year":"2012","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.gde.2005.12.008","article-title":"Stem cells in the etiology and treatment of cancer","volume":"16","author":"Zhang","year":"2006","journal-title":"Curr Opin Genet Dev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000330857","article-title":"Adult pituitary stem cells: from pituitary plasticity to adenoma development","volume":"94","author":"Florio","year":"2011","journal-title":"Neuroendocrinology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12022-013-9235-1","article-title":"Stem cells and cancer stem-like cells in endocrine tissues","volume":"24","author":"Lloyd","year":"2013","journal-title":"Endocr Pathol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ygcen.2009.11.007","article-title":"Stem cells in the pituitary gland: a burgeoning field","volume":"166","author":"Vankelecom","year":"2010","journal-title":"Gen Comp Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/157488812798483467","article-title":"Pituitary stem cells drop their mask","volume":"7","author":"Vankelecom","year":"2012","journal-title":"Curr Stem Cell Res Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2013.08.018","article-title":"Pituitary stem cells: where do we stand?","volume":"385","author":"Vankelecom","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"B24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-3-319-41603-8_7","article-title":"Pituitary stem cells: quest for hidden functions","volume-title":"Stem Cells in Neuroendocrinology","author":"Vankelecom","year":"2016"},{"key":"B25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/sj.bjc.6605142","article-title":"Isolation of tumour stem-like cells from benign tumours","volume":"101","author":"Xu","year":"2009","journal-title":"Br J Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1007\/s12035-016-0025-x","article-title":"Phenotypical and pharmacological characterization of stem-like cells in human pituitary adenomas","volume":"54","author":"W\u00fcrth","year":"2017","journal-title":"Mol Neurobiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s40478-016-0394-4","article-title":"The identification of human pituitary adenoma-initiating cells","volume":"4","author":"Manoranjan","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"B28","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1530\/ERC-14-0546","article-title":"Pituitary tumors contain a side population with tumor stem cell-associated characteristics","volume":"22","author":"Mertens","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e76550","DOI":"10.1371\/journal.pone.0076550","article-title":"The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis","volume":"8","author":"Wouters","year":"2013","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e73968","DOI":"10.1371\/journal.pone.0073968","article-title":"Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes","volume":"8","author":"Van den broeck","year":"2013","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mce.2010.02.012","article-title":"Pituitary senescence: the evolving role of PTTG","volume":"326","author":"Chesnokova","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.stem.2013.07.004","article-title":"Sox2(+) stem\/progenitor cells in the adult mouse pituitary support organ homeostasis and have tumor-inducing potential","volume":"13","author":"Andoniadou","year":"2013","journal-title":"Cell Stem Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e4815","DOI":"10.1371\/journal.pone.0004815","article-title":"A GRFa2\/Prop1\/stem (GPS) cell niche in the pituitary","volume":"4","author":"Garcia-Lavandeira","year":"2009","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1242\/dev.150490","article-title":"MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma","volume":"144","author":"Haston","year":"2017","journal-title":"Development"},{"key":"B35","doi-asserted-by":"publisher","first-page":"6332","DOI":"10.1073\/pnas.0801644105","article-title":"Genetic approaches identify adult pituitary stem cells","volume":"105","author":"Gleiberman","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B36","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.stem.2012.09.014","article-title":"p27(Kip1) directly represses Sox2 during embryonic stem cell differentiation","volume":"11","author":"Li","year":"2012","journal-title":"Cell Stem Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1210\/me.2004-0403","article-title":"Early multipotential pituitary focal hyperplasia in the alpha-subunit of glycoprotein hormone-driven pituitary tumor-transforming gene transgenic mice","volume":"19","author":"Abbud","year":"2005","journal-title":"Mol Endocrinol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1093\/hmg\/10.11.1141","article-title":"Persistent Prop1 expression delays gonadotrope differentiation and enhances pituitary tumor susceptibility","volume":"10","author":"Cushman","year":"2001","journal-title":"Hum Mol Genet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1267\/ahc.08007","article-title":"Pituitary changes in Prop1 transgenic mice: hormone producing tumors and signet-ring type gonadotropes","volume":"41","author":"Egashira","year":"2008","journal-title":"Acta Histochem Cytochem"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e35943","DOI":"10.1371\/journal.pone.0035943","article-title":"GFAP-Cre-mediated transgenic activation of Bmi1 results in pituitary tumors","volume":"7","author":"Westerman","year":"2012","journal-title":"PLoS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1210\/en.2012-1152","article-title":"The adult pituitary shows stem\/progenitor cell activation in response to injury and is capable of regeneration","volume":"153","author":"Fu","year":"2012","journal-title":"Endocrinology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1089\/scd.2012.0290","article-title":"Regenerative capacity of the adult pituitary: multiple mechanisms of lactotrope restoration after transgenic ablation","volume":"21","author":"Fu","year":"2012","journal-title":"Stem Cells Dev"},{"key":"B43","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1210\/en.2015-1741","article-title":"Regeneration in the pituitary after cell-ablation injury: time-related aspects and molecular analysis","volume":"157","author":"Willems","year":"2016","journal-title":"Endocrinology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/humu.21606","article-title":"SOX2 haploinsufficiency is associated with slow progressing hypothalamo-pituitary tumours","volume":"32","author":"Alatzoglou","year":"2011","journal-title":"Hum Mutat"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1111\/j.1460-9568.2010.07523.x","article-title":"Pituitary stem\/progenitor cells: embryonic players in the adult gland?","volume":"32","author":"Vankelecom","year":"2010","journal-title":"Eur J Neurosci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"57072","DOI":"10.18632\/oncotarget.19046","article-title":"Notch system is differentially expressed and activated in pituitary adenomas of distinct histotype, tumor cell lines and normal pituitaries","volume":"8","author":"Perrone","year":"2017","journal-title":"Oncotarget"},{"key":"B47","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3892\/ol.2013.1113","article-title":"Overexpression of the Notch3 receptor and its ligand Jagged1 in human clinically non-functioning pituitary adenomas","volume":"5","author":"Lu","year":"2013","journal-title":"Oncol Lett"},{"key":"B48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.14310\/horm.2002.1570","article-title":"The role of Notch and Hedgehog signaling pathways in pituitary development and pathogenesis of pituitary adenomas","volume":"14","author":"Yavropoulou","year":"2015","journal-title":"Hormones"},{"key":"B49","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neulet.2015.10.076","article-title":"Expression pattern of the Hedgehog signaling pathway in pituitary adenomas","volume":"611","author":"Yavropoulou","year":"2015","journal-title":"Neurosci Lett"},{"key":"B50","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11102-007-0082-2","article-title":"Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses","volume":"11","author":"Evans","year":"2008","journal-title":"Pituitary"},{"key":"B51","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12022-008-9048-9","article-title":"Expression of Wnt4 in human pituitary adenomas regulates activation of the \u03b2-catenin-independent pathway","volume":"19","author":"Miyakoshi","year":"2008","journal-title":"Endocr Pathol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1530\/ERC-13-0005","article-title":"Wnt signalling in pituitary development and tumorigenesis","volume":"20","author":"Chambers","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1210\/en.2011-1216","article-title":"Inactivation of PITX2 transcription factor induced apoptosis of gonadotroph tumoral cells","volume":"152","author":"Acunzo","year":"2011","journal-title":"Endocrinology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/MED.0b013e328354b2e2","article-title":"Pituitary adenoma pathogenesis: an update","volume":"19","author":"Rostad","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B55","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40478-015-0211-5","article-title":"Identification of targets for rational pharmacological therapy in childhood craniopharyngioma","volume":"3","author":"Gump","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"B56","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40478-016-0287-6","article-title":"Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles","volume":"4","author":"H\u00f6lsken","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"B57","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/jnen\/nlw116","article-title":"Genomic alterations of adamantinomatous and papillary craniopharyngioma","volume":"76","author":"Goschzik","year":"2017","journal-title":"J Neuropathol Exp Neurol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nrc1694","article-title":"Opinion: migrating cancer stem cells \u2013 an integrated concept of malignant tumour progression","volume":"5","author":"Brabletz","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc3447","article-title":"Regulatory networks defining EMT during cancer initiation and progression","volume":"13","author":"De Craene","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B60","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"B61","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits","volume":"9","author":"Polyak","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B62","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.semcancer.2012.04.001","article-title":"Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links","volume":"22","author":"Scheel","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e66927","DOI":"10.1371\/journal.pone.0066927","article-title":"Attenuated RORC expression in the presence of EMT progression in somatotroph adenomas following treatment with somatostatin analogs is associated with poor clinical recovery","volume":"8","author":"Lekva","year":"2013","journal-title":"PLoS One"},{"key":"B64","doi-asserted-by":"publisher","first-page":"24928","DOI":"10.1038\/srep24928","article-title":"Hedgehog signaling activation induces stem cell proliferation and hormone release in the adult pituitary gland","volume":"6","author":"Pyczek","year":"2016","journal-title":"Sci Rep"},{"key":"B65","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1530\/ERC-15-0109","article-title":"The role of proto-oncogene GLI1 in pituitary adenoma formation and cell survival regulation","volume":"22","author":"Lampichler","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"B66","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1530\/EJE-14-0934","article-title":"Sonic Hedgehog pathway is upregulated in adamantinomatous craniopharyngiomas","volume":"172","author":"Gomes","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","article-title":"Elucidation of a universal size-control mechanism in Drosophila and mammals","volume":"130","author":"Dong","year":"2007","journal-title":"Cell"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1073\/pnas.0911427107","article-title":"Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver","volume":"107","author":"Lu","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B69","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrc3458","article-title":"The Hippo pathway and human cancer","volume":"13","author":"Harvey","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B70","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF02914988","article-title":"Proliferation markers and EGF in ACTH-secreting adenomas and carcinomas of the pituitary","volume":"6","author":"Lubke","year":"1995","journal-title":"Endocr Pathol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1210\/jcem.81.2.8636285","article-title":"Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness","volume":"81","author":"LeRiche","year":"1996","journal-title":"Clin Endocrinol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nrc926","article-title":"The pathogenesis of pituitary tumours","volume":"2","author":"Asa","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"B73","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/modpathol.3800118","article-title":"Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomas","volume":"17","author":"Onguru","year":"2004","journal-title":"Mod Pathol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1530\/ERC-11-0066","article-title":"Expression and function of ErbB receptors and ligands in the pituitary","volume":"18","author":"Cooper","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"B75","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1172\/JCI60417","article-title":"EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas","volume":"121","author":"Fukuoka","year":"2011","journal-title":"J Clin Invest"},{"key":"B76","first-page":"458","article-title":"Expression of Eag1 K+ channel and erbbs in human pituitary adenomas: cytoskeleton arrangement patterns in cultured cells","volume":"6","author":"del Pliego","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.mce.2015.08.024","article-title":"Animal models of pituitary neoplasia","volume":"421","author":"Lines","year":"2016","journal-title":"Mol Cell Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2017.00339\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T04:26:41Z","timestamp":1512361601000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2017.00339\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,4]]},"references-count":77,"alternative-id":["10.3389\/fendo.2017.00339"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2017.00339","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,4]]},"article-number":"339"}}